Composition
- Active ingredients
- BREMELANOTIDE ACETATE EQ 1.75MG BASE/0.3ML (EQ 1.75MG BASE/0.3 ML)
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA210557.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Vyleesi (Autoinjector)
- Active substance
- bremelanotide acetate
- Route
- Subcutaneous
- Dosage form
- Solution
- Applicant
- Cosette
- Status
- Prescription
- FDA approval
- 21 Jun 2019
- Application
- NDA210557-001